Wang Xi, Gao Hengyuan, Pu Wenjun, Zeng Zhipeng, Xu Nan, Luo Xunpeng, Tang Donge, Dai Yong
The First Affiliated Hospital (Shenzhen People's Hospital), Southern University of Science and Technology, Shenzhen, 518055, China.
The Fourth Clinical Medical College of Guangzhou, Shenzhen Traditional Chinese Medicine Hospital, University of Chinese Medicine, Shenzhen, 518033, China.
Cancer Cell Int. 2024 Oct 14;24(1):337. doi: 10.1186/s12935-024-03482-3.
Previous studies have indicated that ψ-modified small RNAs play crucial roles in tumor metastasis. However, the ψ-modified small RNAs during metastasis of PTC are still unclear.
We compared the pseudouridine synthase 7 (PUS7) alteration between metastatic and non-metastatic PTCs, and investigated its correlation with clinicopathological features. Additionally, we employed a small RNA ψ modification microarray to examine the small RNA ψ modification profile in both metastatic and non-metastatic PTCs, as well as paired paracancerous tissues. The key molecule involved in ψ modification, pre-miR-8082, was identified and found to regulate the expression of CD47. Experiments in vitro were conducted to further investigate the function of PUS7 and CD47 in PTC.
Our results demonstrated that PUS7 was down-regulated in PTC and was closely associated with metastasis. Moreover, the ψ modification of pre-miR-8082 was found to be decreased, resulting in down-expression of pre-miR-8082 and miR-8082, leading to the loss of the inhibitory effect on CD47, thereby promoting tumor migration.
Our study demonstrates that PUS7 promotes the inhibition of CD47 and inhibits metastasis of PTC cells by regulating the ψ modification of pre-miR-8082. These results suggest that PUS7 and ψ pre-miR-8082 may serve as potential targets and diagnostic markers for PTC metastasis.
先前的研究表明,ψ修饰的小RNA在肿瘤转移中起关键作用。然而,甲状腺乳头状癌(PTC)转移过程中的ψ修饰小RNA仍不清楚。
我们比较了转移性和非转移性PTC中假尿苷合酶7(PUS7)的改变,并研究了其与临床病理特征的相关性。此外,我们使用小RNA ψ修饰微阵列检测转移性和非转移性PTC以及配对癌旁组织中的小RNA ψ修饰谱。鉴定出参与ψ修饰的关键分子pre-miR-8082,并发现其调节CD47的表达。进行体外实验以进一步研究PUS7和CD47在PTC中的功能。
我们的结果表明,PUS7在PTC中下调,并与转移密切相关。此外,发现pre-miR-8082的ψ修饰减少导致pre-miR-8082和miR-8082表达下调,导致对CD47的抑制作用丧失,从而促进肿瘤迁移。
我们的研究表明,PUS7通过调节pre-miR-8082的ψ修饰促进对CD47的抑制并抑制PTC细胞转移。这些结果表明,PUS7和ψ pre-miR-8082可能作为PTC转移的潜在靶点和诊断标志物。